hyperlipidemic acute pancreatitis(HLAP)
Conditions
Interventions
Control group:Western medicine conventional chemotherapy
Intervention group:Western medicine conventional treatment plan plus Chinese medicine treatment
Sponsors
The First Affiliated Hospital of Xingtai Medical College (The First Hospital of Xingtai City)
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) Meet the diagnostic criteria for hyperlipidemia acute pancreatitis in both traditional Chinese medicine and Western medicine; 2) Abdominal CT and/or MRI meet the diagnostic criteria for pancreatitis; 3) The age of the patient is 20-80 years old; 4) There is no previous history of acute pancreatitis 5) Patients and their families who are fully aware of this study and signed the informed consent form agree to receive traditional Chinese medicine decoction treatment, which will remain unchanged in future treatment.
Exclusion criteria
Exclusion criteria: 1) Exclude acute pancreatitis caused by biliary diseases, alcohol consumption, drugs, tumors, etc.; 2) Chronic pancreatitis such as pancreatic calcification or pancreatic duct calcification and calculi visible on CT and/or MRI imaging; 3) Combined with itself Patients with immune diseases; 4) Patients with mental diseases; 5) Those with severe heart, lung, liver, kidney and other organ insufficiency; 7) Those who are allergic to the selected drugs; 8) Those who have any disease leading to a terminal state.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ranson score, APACHE-II score and pancreatic Baltharer CT score; | — |
Countries
China
Contacts
Public ContactYan Zhang
The First Affiliated Hospital of Xingtai Medical College (The First Hospital of Xingtai City)
Outcome results
None listed